HIV immunotherapy comes of age: implications for prevention, treatment and cure

Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies

Immunotherapy in hepatocellular carcinoma: Primed to make a difference?

Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity

Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy

Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy

Immunotherapy for hepatocellular carcinoma

Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4

A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination